Treatment Satisfaction and Disease Control in Patients with chronic spontaneous and induced Urticaria/Angioedema

被引：0
|
作者：
Berndt, K. [1 ]
Roensch, H. [1 ]
Langner, M. [1 ]
Meinel, G. [1 ]
Beissert, S. [1 ]
Bauer, A. [1 ]
机构：
[1] Univ Klinikum Carl Gustav Carus, Klin & Poliklin Dermatol, Allergie Centrum, Dresden, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2019年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P336
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [41] Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria
    Curto-Barredo, L.
    Spertino, J.
    Figueras-Nart, I.
    Exposito-Serrano, V.
    Guilabert, A.
    Mele-Ninot, G.
    Cubiro, X.
    Bonfill-Orti, M.
    Garcias-Ladaria, J.
    Villar, M.
    Garcia-Navarro, X.
    Bielsa-Marsol, I.
    Vilavella, M.
    Aparicio, G.
    Baliu-Pique, C.
    Alvarez, A.
    Lamas-Domenech, N.
    Duran-Jorda, X.
    Serra-Baldrich, E.
    Gimenez-Arnau, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 210 - 212
  • [42] A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema
    Magen, Eli
    Merzon, Eugene
    Green, Ilan
    Magen, Israel
    Waitman, Dan-Andrei
    Kahan, Natan R.
    ALLERGY AND ASTHMA PROCEEDINGS, 2023, 44 (02) : 122 - 129
  • [43] The first experience of treatment with omalizumab of patients with chronic spontaneous urticaria with angioedema, with severe refractory course, associated with autoimmune thyroiditis
    Tussupbekova, G.
    ALLERGY, 2021, 76 : 245 - 246
  • [44] Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria
    Mao, Manyun
    Liu, Hong
    Yan, Siyu
    Yuan, Yan
    Liu, Runqiu
    Wu, Yingfang
    Peng, Cong
    Li, Jie
    Chen, Xiang
    ALLERGY, 2021, 76 (02) : 571 - 573
  • [45] Omalizumab Treatment and Outcomes in Chinese Patients with Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, or Both
    Chen, Yudi
    Miao, Yu
    Tu, Ping
    Maurer, Marcus
    Zhao, Zuotao
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB25 - AB25
  • [46] Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
    Chen, Yudi
    Yu, Miao
    Huang, Xiaojie
    Tu, Ping
    Shi, Peikun
    Maurer, Marcus
    Zhao, Zuotao
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (01):
  • [47] Is There a Difference in Omalizumab Treatment Response in Patients With Chronic Autoimmune Urticaria vs Chronic Spontaneous Urticaria?
    Khalsa, Kiranjit K.
    Patel, Gargi
    Testo, Natalia
    Pasha, Muhammad A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB57 - AB57
  • [48] Ligelizumab achieves sustained control of chronic spontaneous urticaria symptoms of hives, itch and angioedema: 1-year treatment results
    Bernstein, J. A.
    Baker, D.
    Maurer, M.
    Gimenez-Arnau, A. M.
    Sussman, G.
    Barve, A.
    Hua, E.
    Severin, T.
    Janocha, R.
    ALLERGY, 2019, 74 : 21 - 21
  • [49] Omalizumab effectively reduces angioedema episodes in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 18 - 18
  • [50] Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria
    Akenroye, Ayobami T.
    McEwan, Conor
    Saini, Sarbjit S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (04): : 1403 - 1405
12345